A Study of Atezolizumab Compared With Chemotherapy in Treatment Na ïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Containing Therapy

Condition:   Non-Small Cell Lung Cancer Interventions:   Drug: Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody;   Drug: Vinorelbine;   Drug: Gemcitabine Sponsor:   Hoffmann-La Roche Not yet recruiting - verified June 2017 (Source: ClinicalTrials.gov)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2rAgod4
via IFTTT